OptiNose (NASDAQ: OPTN) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $20.55 million.

GUIDANCE:

OptiNose sees FY2022 revenue of $85-92 million, versus the consensus of $91 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.